Isentress and Schizophrenia - a phase IV clinical study of FDA data

Summary:

Schizophrenia is reported as a side effect among people who take Isentress (raltegravir potassium), especially for people who are male, 30-39 old, have been taking the drug for 2 - 5 years also take Cymbalta, and have Asthma.

The phase IV clinical study analyzes which people have Schizophrenia when taking Isentress. It is created by eHealthMe based on reports of 16,310 people who have side effects when taking Isentress from the FDA, and is updated regularly.

What is Isentress?

Isentress has active ingredients of raltegravir potassium. It is often used in hiv infection. eHealthMe is studying from 16,529 Isentress users. Check the latest studies of Isentress.

What is Schizophrenia?

Schizophrenia (a mental disorder characterized by a breakdown of thought processes) is found to be associated with 510 drugs and 724 conditions by eHealthMe. Check the latest studies of Schizophrenia.

On Jul, 08, 2026

16,310 people reported to have side effects when taking Isentress.
Among them, 26 people (0.16%) have Schizophrenia.

Among these 26 people:

How long have people been on Isentress when they have Schizophrenia? *

What is the gender of people who have Schizophrenia when taking Isentress? *

female: 13.04 %
male: 86.96 %

What is the age of people who have Schizophrenia when taking Isentress? *

What are other drugs people take besides Isentress? *

What are other side effects people have besides Schizophrenia? *

Diabetes: 18 people, 69.23%
Electrocardiogram Abnormal: 18 people, 69.23%
Gastroenteritis (inflammation of stomach and intestine): 18 people, 69.23%
Insomnia (sleeplessness): 18 people, 69.23%
Bedwetting: 18 people, 69.23%
Stomatitis (inflammation of mucous membrane of mouth): 15 people, 57.69%
Pruritus Genital (uneasy irritation of the skin of the vagina and the surrounding area): 15 people, 57.69%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 15 people, 57.69%
Renal Impairment (severely reduced kidney function): 10 people, 38.46%
Joint Pain: 10 people, 38.46%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 69.23%
Dyslipidaemia (abnormal amount of lipids): 18 people, 69.23%
Asthma: 18 people, 69.23%
Diabetes: 8 people, 30.77%
Abnormal Sensation In Eye: 8 people, 30.77%

* Approximation only. Some reports may have incomplete information.

Do you take Isentress and have Schizophrenia?

- Check whether Schizophrenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Isentress:

Isentress (16,529 reports)

Schizophrenia treatments and more:

Schizophrenia (130,798 reports)

Browse all side effects of Isentress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Schizophrenia:

Schizophrenia (510 drugs)

Browse all the conditions that are associated with Schizophrenia:

Schizophrenia (724 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raltegravir potassium (the active ingredients of Isentress) and Isentress (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.